BCL2 and cancer: Although the study concerned another anti-apoptotic protein, Bcl-2, it showed that the imbalance between the pro- and anti-apoptotic proteins may significantly increase sensitivity of the examined cancer cells to the cytostatic drugs commonly used in the therapy.